Antipsychotic Prescription Rate and Drug Monitoring for Patients with PDD Before and After COVID19 (P6-6.014)
This study aims to evaluate the rate of prescription and effectiveness of drug monitoring of antipsychotic prescriptions assigned to patients with Pervasive Developmental Disorders (PDD) across socioeconomic and racial backgrounds in Southern California before and after the COVID19 pandemic.
Authors
- Christopher Scott Colwell (ORCID: https://orcid.org/0000-0002-1059-184X)
- D P Davies
- J.V. Tuschhoff
- Cristina A. Ghiani (ORCID: https://orcid.org/0000-0002-9867-6185)
- Deap S Bhandal
- Kyle Nguyen-Ngo
Institutions
- University of California, Los Angeles (US)
- University of Missouri–Kansas City (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212411
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 0.00